Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Orthopaedics and Trauma
Orthopaedics and Trauma publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 12 (Search time: 0.001 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
Butler, L.
;
Liapis, V.
;
Bouralexis, S.
;
Welldon, K.
;
Hay, S.
;
Thai, L.
;
Labrinidis, A.
;
Tilley, W.
;
Findlay, D.
;
Evdokiou, A.
2001
Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL
Clayer, M.
;
Bouralexis, S.
;
Evdokiou, A.
;
Hay, S.
;
Atkins, G.
;
Findlay, D.
2004
Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin
Bouralexis, S.
;
Clayer, M.
;
Atkins, G.
;
Labrinidis, A.
;
Hay, S.
;
Graves, S.
;
Findlay, D.
;
Evdokiou, A.
2002
Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism
Findlay, D.
;
Raggatt, L.
;
Bouralexis, S.
;
Hay, S.
;
Atkins, G.
;
Evdokiou, A.
2005
Death to the bad buys: Targeting cancer via Apo2L/TRAIL
Bouralexis, S.
;
Findlay, D.
;
Evdokiou, A.
2002
Zoledronate is anabolic for human osteoblast-like cells
Atkins, G.
;
Pan, B.
;
Findlay, D.
;
To, L.
;
Evdokiou, A.
;
Labrinidis, A.
;
Bouralexis, S.
;
Zannettino, A.
;
American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2002
Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to APO2L/TRIAL-induced apoptosis
Evdokiou, A.
;
Bouralexis, S.
;
Atkins, G.
;
Chai, F.
;
Hay, S.
;
Clayer, M.
;
Findlay, D.
2001
Chemotherapeutic drugs sensitise osteogenic sarcoma cells but not normal human bone cells to TRAIL-mediated apoptosis
Atkins, G.
;
Evdokiou, A.
;
Bouralexis, S.
;
Chai, F.
;
Hay, S.
;
Clayer, M.
;
Findlay, D.
2003
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
Bouralexis, S.
;
Findlay, D.
;
Atkins, G.
;
Labrinidis, A.
;
Hay, S.
;
Evdokiou, A.
2002
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
Atkins, G.
;
Bouralexis, S.
;
Evdokiou, A.
;
Hay, S.
;
Labrinidis, A.
;
Zannettino, A.
;
Haynes, D.
;
Findlay, D.
Discover
Author
12
Evdokiou, A.
12
Findlay, D.
10
Hay, S.
9
Atkins, G.
6
Labrinidis, A.
4
Clayer, M.
2
Chai, F.
2
Graves, S.
2
Haynes, D.
2
Zannettino, A.
.
next >
Subject
5
apoptosis
4
Apo2L
3
Apo2L/TRAIL
3
Apoptosis
3
chemotherapy
3
osteosarcoma
3
TRAIL
2
Apoptosis Regulatory Proteins
2
bone
2
Bone Neoplasms
.
next >
Date issued
1
2006
1
2005
1
2004
2
2003
4
2002
2
2001
1
2000